Purpose: The summary presented herein represents Part I of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment …

Purpose: The summary presented herein represents Part II of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing principles of …

Purpose: The summary presented herein represents Part III of the three-part series
dedicated to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing …

Purpose: This guideline is structured to provide a clinical framework stratified by cancer
severity to facilitate care decisions and guide the specifics of implementing the selected …

Purpose: This guideline is structured to provide a clinical framework stratified by cancer
severity to facilitate care decisions and guide the specifics of implementing the selected …

In April 2017, the American Urological Association, American Society for Radiation
Oncology, and Society of Urologic Oncology released a joint evidence-based practice …

Abstract Purpose: The American Urological Association convened the Prostate Cancer
Clinical Guidelines Panel to analyze the literature regarding available methods for treating …

Purpose Following a prostate cancer diagnosis, patients are faced with a multitude of care
options, the advisability of which is influenced by patient factors and by cancer severity or …

In December 1995, the AUA published the Report on the Management of Clinically
Localized Prostate Cancer. 1 The document was the culmination of six years of work by 17 …

PURPOSE:: Pretreatment risk assessment models facilitate more appropriate selection of
treatment for prostate cancer. However, men with high risk disease remain a challenge with …